ABC News: Ivermectin, condemned by experts as COVID-19 treatment, continues to be easily accessible through telemedicine

ABC News: Ivermectin, condemned by experts as COVID-19 treatment, continues to be easily accessible through telemedicine. “Ivermectin advocates often cite ‘dozens’ of studies that show benefits of ivermectin in combating COVID-19, but a closer look at the studies shows that some of them have been retracted for flawed or fabricated data and analysis, while many randomized trials have shown no benefits. There have been some small studies that did suggest positive effects of ivermectin on treating COVID-19 patients, but no large, rigorous, randomized controlled trial has shown that ivermectin is effective at treating or preventing COVID-19, medical experts say.”

Grand Forks Herald: South Dakota House OKs bill saying parasite-killing drug can be prescribed to humans

Grand Forks Herald: South Dakota House OKs bill saying parasite-killing drug can be prescribed to humans. “Supporters of ivermectin as a drug to treat COVID-19 won on a new frontier Monday, Feb. 14, in the South Dakota Legislature. Lawmakers in the House of Representatives passed a bill specifying that the drug could be legally prescribed in the state. The bill was despite the largely held opinion of the medical community that ivermectin is not an appropriate drug to treat COVID-19.”

Washington Post: Mexico City gave ivermectin to thousands of covid patients. Officials face an ethics backlash.

Washington Post: Mexico City gave ivermectin to thousands of covid patients. Officials face an ethics backlash.. “As the coronavirus coursed through Mexico City early last year, ravaging neighborhoods and overwhelming hospitals, local officials made an unusual decision. They gave out tens of thousands of medical kits to covid-19 patients containing ivermectin, an anti-parasitic medication. The drug has been championed by anti-vaccine activists around the world as a cure for covid-19 — despite warnings from international health authorities that there’s insufficient evidence of any such benefit.”

NPR: What a bottle of ivermectin reveals about the shadowy world of COVID telemedicine

NPR: What a bottle of ivermectin reveals about the shadowy world of COVID telemedicine. “Data shows that prescriptions for drugs like ivermectin have surged in the pandemic, but patient-doctor confidentiality often obscures exactly who is handing out the drugs. [Ben] Bergquam’s testimonial provides new and troubling details about a small group of physicians who are willing to eschew the best COVID-19 treatments and provide alternative therapies made popular by disinformation — for a price.”

Kansas Reflector: Kansas senator under investigation after prescribing ivermectin for COVID-19, seeks legal cover

Kansas Reflector: Kansas senator under investigation after prescribing ivermectin for COVID-19, seeks legal cover. “Sen. Mark Steffen revealed Wednesday he is under investigation for prescribing ivermectin to COVID-19 patients, accused the chief medical director of the University of Kansas Health System of spreading propaganda, and challenged him to a public debate.”

New York Times: Detainees Sue Arkansas Jail That Gave Them Ivermectin to Treat Covid

New York Times: Detainees Sue Arkansas Jail That Gave Them Ivermectin to Treat Covid. “Detainees at an Arkansas jail who had Covid-19 were unknowingly treated by the detention center’s doctor with ivermectin, a drug that health officials have continually said is dangerous and should not be used to treat or prevent a coronavirus infection, according to a federal lawsuit filed by the American Civil Liberties Union on behalf of four detainees.”

Ivermectin Rx for COVID-19: Insurance coverage doesn’t match evidence (University of Michigan)

University of Michigan: Ivermectin Rx for COVID-19: Insurance coverage doesn’t match evidence. “Even though clinical trials haven’t shown it works against COVID-19, doctors continue to prescribe ivermectin – and a new study suggests health insurers are heavily subsidizing the cost of those prescriptions. The study’s authors call for insurers to align their coverage of the drug with the level of medical evidence surrounding it — just like they do for other medications, tests and procedures.”